Browse by Tags

In order to prevent and ultimately achieve a world without type 1 diabetes (T1D), we must first learn more about the disease. One trend that has revealed itself in recent years is an accelerating rate of T1D, especially among younger children. Last year, the SEARCH for Diabetes in Youth study reported...

In June, the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) released results from their latest SEARCH for Diabetes in Youth study . The data revealed a 23 percent growth in type 1 diabetes (T1D) prevalence, between 2001 and 2009, in Americans under age 20...

In a recent study published in the current issue of Nature Immunology , a JDRF-funded team led by Dr. Diane Mathis from the Harvard Medical School and Massachusetts General Hospital developed a technique that uses MRI and nanoparticles for predicting type 1 diabetes (T1D). In the study, which was conducted...

JDRF-funded scientists at Yale University recently found a mechanism of action by which teplizumab, an anti-CD3 antibody may be working as an immune therapy for T1D. Currently, once T1D starts to develop, there’s no intervention developed to stop it. The immune system slowly and inevitably kills...

As we inch toward the end of 2011, a look back over the past few months shows a great deal of progress in JDRF’s efforts toward curing, treating, and preventing type 1 diabetes (T1D) and its complications. Check out the latest key advances from the first quarter of fiscal year 2012 (July through...

Last week, JDRF-funded researchers from the La Jolla Institute for Allergy and Immunology in San Diego, California announced that they had created the first 3-dimensional movies depicting the destruction of insulin-producing beta cells – the process that ultimately leads to type 1 diabetes (T1D...

As new cases of type 1 diabetes (T1D) increase worldwide , JDRF has continued to focus on preventing T1D in those at risk. By the time symptoms of T1D appear, however, the destruction of insulin producing beta cells may have already been occurring for some time. In order to effectively prevent the disease...

At the recent American Diabetes Association 71 st Scientific Sessions in San Diego the results of several clinical trials focused on finding a cure for type 1 diabetes were announced. Most of these trials tested drugs administered to people with type 1 diabetes to curb the autoimmune attack on the beta...

As previous News Blog entries have covered, researchers are working to determine how genetics and environmental factors contribute to the development of type 1 diabetes. A number of recent studies (including this one and this one , published in the journal Diabetes ) have indicated that enteroviruses...

The number of Americans affected by diabetes is growing. According to 2011 estimates released last week by the Centers for Disease Control and Prevention (CDC), some 26 million people in the U.S. have diabetes – both type 1 and type 2. The new figure marks an 8.3 percent increase from the CDC’s...

Researchers are still trying to get a clear picture about how genes and environmental factors interact to determine a person’s risk of developing type 1 diabetes. While researchers have identified several genes that lead to increased risk of developing type 1 diabetes, a number of theories exist...